Gastric
& Breast Cancer e-journal
DOI: 10.2122/gbc.2006.0050
NEWS & VIEWS
|
Positive Perioperative (ECF) Chemotherapy Trial for Gastric Cancer: Primary chemotherapy or surgery?
|
Evangelos Briasoulis, MD, Theodore Liakakos, MD, Nikolaos Xeropotamos, Dimosthenis Ziogas, MD,
Dimitrios Roukos,* MD, and Michael Fatouros, MD
|
| |
The MAGIC trial provides, for a first time in the literature, level I evidence for a survival benefit of a new treatment option. However, the trial was designed to provide overall data for all patients with stage II, IIIA and IIIB and not not stage-specific subgroups survival analysis. Although the study provides robust results, can perioperative chemotherapy replace current standard surgery in the clinical treatment practice of operable gastric cancer?
|
|
| |
|
|
|
|
Find Delta Dental, MetLife Dental, Aetna Dentist, New York Dentist, San Francisco Dentist, Boston Dentist, Chicago Dentist, Los Angeles Dentist & San Diego Dentist at DoctorsImprovingHealthcare.org. Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 3 February 2004 |
|
|
|
